acute lymphoblastic leukemia

Amgen’s Blincyto approved by FDA for new acute lymphoblastic leukaemia indication
PM Live
Mon, 06/17/24 - 10:28 pm
Amgen
FDA
Blincyto
acute lymphoblastic leukemia
FDA Approves Iclusig for New Patients with Aggressive Leukemia
Managed Healthcare Executive
Tue, 03/19/24 - 09:20 pm
Takeda
Iclusig
FDA
acute lymphoblastic leukemia
Takeda's Iclusig shows potential to become standard of care in acute lymphoblastic leukemia subtype
Fierce Pharma
Wed, 02/15/23 - 06:16 pm
Takeda
Iclusig
acute lymphoblastic leukemia
ALL
ASCO
Jazz plays coda to blood cancer approval, securing FDA nod for revised dosing schedule
Fierce Pharma
Tue, 11/22/22 - 04:41 pm
Jazz Pharmaceuticals
FDA
Rylaze
blood cancer
acute lymphoblastic leukemia
lymphoblastic lymphoma
Takeda touts positive first-line leukemia results — but isn't quite ready to reveal the hard data
Endpoints
Thu, 11/17/22 - 11:36 pm
Takeda
Ariad Pharmaceuticals
Iclusig
clinical trials
acute lymphoblastic leukemia
Kite gets US FDA approval for Tecartus to treat acute lymphoblastic leukemia
Pharmaceutical Business Review
Mon, 10/4/21 - 10:39 am
Kite Pharma
Gilead Sciences
Tecartus
FDA
ALL
acute lymphoblastic leukemia
Jazz Pharma (JAZZ) Gets FDA Approval for Leukemia Drug Rylaze
Yahoo/Zacks.com
Thu, 07/1/21 - 10:33 am
Jazz Pharmaceuticals
FDA
Rylaze
JZP-458
acute lymphoblastic leukemia
lymphoblastic lymphoma
The FDA Accepts Bristol-Myers Squibb’s Application for Sprycel in Ph+ Acute Lymphoblastic Leukemia
CP Wire
Thu, 08/30/18 - 10:16 am
Bristol-Myers Squibb
Sprycel
acute lymphoblastic leukemia
FDA
The FDA Accepts Bristol-Myers Squibb’s Application for Sprycel in Ph+ Acute Lymphoblastic Leukemia
Thu, 08/30/18 - 09:44 am
Bristol-Myers Squibb
Sprycel
acute lymphoblastic leukemia
Novartis announces new €78m plant and 450 new jobs to manufacture Kymriah in EU
GoinPharma
Tue, 08/28/18 - 07:58 pm
Novartis
Europe
Kymriah
ALL
acute lymphoblastic leukemia
Acute Lymphoblastic Leukemia in Children Linked to Lack of Healthy Microbiome
Xtalks
Wed, 05/23/18 - 11:56 am
acute lymphoblastic leukemia
pediatric cancer
microbiome
Novartis’ Kymriah: The First Gene Therapy to Be Approved in the US
Market Realist
Mon, 02/19/18 - 09:48 am
Novartis
Kymriah
gene therapy
acute lymphoblastic leukemia
Novartis seeks European approval for cell therapy Kymriah
Reuters
Mon, 11/6/17 - 09:25 am
Novartis
Europe
CAR-T
Kymriah
diffuse large B-cell lymphoma
acute lymphoblastic leukemia
Novartis CEO's Dilemma: Is $475,000 Too Much For A Leukemia Breakthrough? Or Is It Not Enough?
Forbes
Wed, 08/30/17 - 11:53 pm
Novartis
CAR-T
drug pricing
FDA
acute lymphoblastic leukemia
Kymriah
Joe Jimenez
Novartis Wins Historic FDA Nod, Prices CAR-T For Leukemia at $475,000
Xconomy
Wed, 08/30/17 - 11:48 pm
Novartis
FDA
CAR-T
drug pricing
Kymriah
acute lymphoblastic leukemia
Pfizer's Besponsa Is Yet Another Win for the Biopharma Giant
Motley Fool
Sun, 08/20/17 - 11:54 am
Pfizer
Besponsa
acute lymphoblastic leukemia
FDA
The FDA Just Approved a New Pfizer Cancer Drug for a Rare, Vicious Leukemia
Yahoo/Fortune
Fri, 08/18/17 - 04:27 pm
FDA
Pfizer
Besponsa
acute lymphoblastic leukemia
Pfizer’s CD22-targeted cancer drug inotuzumab wins an accelerated OK at FDA
Endpoints
Thu, 08/17/17 - 11:52 pm
Pfizer
inotuzumab ozogamicin
acute lymphoblastic leukemia
FDA panel to focus on safety of Novartis gene therapy drug
Yahoo/Reuters
Mon, 07/10/17 - 09:32 am
FDA
advisory panels
Novartis
gene therapy
CAR-T
acute lymphoblastic leukemia
FDA Grants Priority Review For Amgen's BLINCYTO® (blinatumomab) Supplemental Biologics License Application
Yahoo
Wed, 03/29/17 - 05:01 pm
Amgen
FDA
priority review
Blincyto
acute lymphoblastic leukemia

Pages